Knight Therapeutics (TSE:GUD) Shares Down 2% - Here's Why

Key Points

• Knight Therapeutics shares fell by 2% during mid-day trading, closing at C$5.77, having traded as low as C$5.75.
• The company has a market capitalization of C$575 million and reported a negative price-to-earnings ratio of -21.70.
• Knight Therapeutics is focused on developing and distributing pharmaceutical and consumer health products both in Canada and select international markets.

Knight Therapeutics Inc. (TSE:GUD - ) traded down 2% during mid-day trading on Monday . The stock traded as low as C$5.75 and last traded at C$5.77. 38,920 shares traded hands during mid-day trading, a decline of 39% from the average session volume of 63,437 shares. The stock had previously closed at C$5.89.

Knight Therapeutics Trading Down 2.0%

The firm's 50-day moving average price is C$6.24 and its 200-day moving average price is C$6.03. The company has a quick ratio of 1.79, a current ratio of 3.36 and a debt-to-equity ratio of 7.52. The company has a market cap of C$575.00 million, a P/E ratio of -21.70, a price-to-earnings-growth ratio of -1,013.50 and a beta of 0.05.

Knight Therapeutics Company Profile

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.